Accord And Sandoz Lead Victories At GGB Awards 2022

Firms Win Multiple Awards Alongside Other Companies Recognized In Frankfurt

Accord and Sandoz were the big winners at the Global Generics & Biosimilars Awards 2022 in Frankfurt, with other firms recognized including Beximco, Centrient, Dr Reddy’s, Eurofarma, Samsung Bioepis, Shanghai Henlius Biotech and Stada, as well as the US Biosimilars Forum.

GGB Awards 2022 winners group photo
Companies were rewarded across 14 categories • Source: Generics Bulletin

Accord Healthcare and Sandoz have emerged as the major winners at the Global Generics & Biosimilars Awards 2022, with Accord picking up four trophies and Sandoz being crowned the winner in two categories and receiving a commendation in a third, alongside multiple other prizes handed out in Frankfurt, Germany, on 2 November.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Generics

More from Products